Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hall

Showing results (341-350 of 387) with videos related to

Pageof 39
Sort By:
Journal of Medicinal Chemistry|September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer CellsKe Kong, Wei Zhao, Jonathan H Shrimp, et al.
Free Radical Biology & Medicine|February 7, 2026
What Lies Beyond Thioredoxin Reductase? Cyclometallated gold Compounds Reveal Sec Selectivity in Glutathione PeroxidasesIoannis Kanavos, Douglas H Nakahata, Madeleine S Barrett, et al.
Orphanet Journal of Rare Diseases|November 27, 2024
Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy - meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of AmericaEmma Rybalka, Hyung Jun Park, Atchayaram Nalini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Cancer Cell|December 12, 2018
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer RemodelingAmanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, et al.
Journal of Virology|January 29, 2016
Spatiotemporal Analysis of the Genetic Diversity of Seal Influenza A(H10N7) Virus, Northwestern EuropeRogier Bodewes, Siamak Zohari, Jesper S Krog, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2020
Improving the Pediatric Patient Experience During Radiation Therapy-A Children's Oncology Group StudyDouglas E Holt, Susan M Hiniker, John A Kalapurakal, et al.
Cell Chemical Biology|July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse CompoundsJohn R Horton, Xu Liu, Molly Gale, et al.
Pageof 39

Showing results (341-350 of 387) with videos related to

Sort By:
Pageof 39
Journal of Medicinal Chemistry|September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer CellsKe Kong, Wei Zhao, Jonathan H Shrimp, et al.
Free Radical Biology & Medicine|February 7, 2026
What Lies Beyond Thioredoxin Reductase? Cyclometallated gold Compounds Reveal Sec Selectivity in Glutathione PeroxidasesIoannis Kanavos, Douglas H Nakahata, Madeleine S Barrett, et al.
Orphanet Journal of Rare Diseases|November 27, 2024
Current insights in ultra-rare adenylosuccinate synthetase 1 myopathy - meeting report on the First Clinical and Scientific Conference. 3 June 2024, National Centre for Advancing Translational Science, Rockville, Maryland, the United States of AmericaEmma Rybalka, Hyung Jun Park, Atchayaram Nalini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Journal of Medicinal Chemistry|November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5AJohn R Horton, Clayton B Woodcock, Qin Chen, et al.
Cancer Cell|December 12, 2018
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer RemodelingAmanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, et al.
Journal of Virology|January 29, 2016
Spatiotemporal Analysis of the Genetic Diversity of Seal Influenza A(H10N7) Virus, Northwestern EuropeRogier Bodewes, Siamak Zohari, Jesper S Krog, et al.
Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2020
Improving the Pediatric Patient Experience During Radiation Therapy-A Children's Oncology Group StudyDouglas E Holt, Susan M Hiniker, John A Kalapurakal, et al.
Cell Chemical Biology|July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse CompoundsJohn R Horton, Xu Liu, Molly Gale, et al.
Pageof 39